6 assets in Dry Eye Syndrome

Therapeutic assets addressing Dry Eye Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclosporin A Dry Eye Syndrome	Barbara Burgos Blasco	P4	BBB (72)
Insulin Human Dry Eye Syndrome	Khyber Teaching Hospital	P4	BB (65)
Vitamin D Dry Eye Syndrome	University of Faisalabad	P3	BB (64)
Diluent Dry Eye Syndrome	Instituto de Oftalmología Fundación Conde de Valenciana	P3	B (60)
Acthar Dry Eye Syndrome	Toyos Clinic	P4	CCC (48)
Pluripotent Stem Cell-Derived Mesenchymal Stem Cell Exosome Eye Drops Dry Eye Syndrome	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1/2	NR ()